Skip directly to site content Skip directly to page options Skip directly to A-Z link


Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
														Search

		Submit


Tuberculosis (TB)


Facebook
        Twitter
        LinkedIn
        Syndicate





Guide to the Application of Genotyping to Tuberculosis Prevention and Control										Related Pages
										**Appendix B: References and Useful Resources**
**References Cited in the Guide**
Barnes 2003
Barnes PF, Cave MD. Molecular Epidemiology of Tuberculosis. N Engl J Med 2003;349:1149-56.Bennett 2002
Bennett DE, Onorato IM, Ellis BA, et al. DNA fingerprinting of *Mycobacterium tuberculosis* isolates from epidemiologically linked case pairs. Emerg Infect Dis 2002;8:1224-9.Bifani 1996
Bifani P, Plikaytis BB, Kapur V, et al. Origin and spread of a New York City multidrug-resistant *Mycobacterium tuberculosis* close family. JAMA 1996;275:452-7.Braden 1997
Braden CR, Templeton GL, Cave MD, et al. Interpretation of restriction fragment length polymorphism analysis of *Mycobacterium tuberculosis* isolates from a state with a large rural population. J Infect Dis 1997;175:1446-52.Castro 2002
Castro KG, Jaffe HW. Rationale and methods for the National Tuberculosis Genotyping and Surveillance Network. Emerg Infect Dis 2002;8:1188-91.Cronin 2002
Cronin WA, Golub JE, Lathan MJ, et al. Molecular epidemiology of tuberculosis in a low-to moderate-incidence state: are contact investigations enough? Emerg Infect Dis 2002;8:1271-9.Jasmer 2002
Jasmer RM, Roemer M, Hamilton J, et al. A prospective, multicenter study of laboratory cross-contamination of *Mycobacterium tuberculosis* cultures. Emerg Infect Dis 2002;8:1260-3.Kamerbeek 1997
Kamerbeek J, Schouls L, Kolk A, et al. Simultaneous detection and strain differentiation of *Mycobacterium tuberculosis* for diagnosis and epidemiology. J Clin Microbiol 1997; 35:907-14Kong 2002
Kong PM, Tapy J, Calixto P, et al. Skin-test screening and tuberculosis transmission among the homeless. Emerg Infect Dis 2002;8:1280-4.Mazars 2001
Mazars E, Lesjean S, Banuls L, et al. High-resolution minisatellite-based typing as a portable approach to global analysis of *Mycobacterium tuberculosis* molecular epidemiology. Proc Nat Acad Sci USA 2001;98:1901-6.McElroy 2002
McElroy PD, Sterling TR, Driver CR, Kreiswirth B, et al. Use of DNA fingerprinting to investigate a multiyear, multistate tuberculosis outbreak. Emerg Infect Dis 2002;8:1251-8.McElroy 2003
McElroy PD, Southwick KL, Fortenberry ER, Levine EC, Diem LA, Woodley CL. Outbreak of tuberculosis among homeless persons coinfected with human immunodeficiency virus. Clin Infect Dis 2003;36:1305-12.McNabb 2004
McNabb SJN, Kammerer JS, Hickey AC, et al. Added epidemiologic value to tuberculosis prevention and control of the investigation of clustered genotypes of *Mycobacterium tuberculosis* isolates. Amer J Epi 2004 (in press).Miller 2002
Miller AC, Sharnprapai S, Suruki R, et al. Impact of genotyping of *Mycobacterium tuberculosis* on public health practice in Massachusetts. Emerg Infect Dis 2002;8:1285-9.Munsiff 2002
Munsiff SS, Bassoff T, Nivin B, et al. Molecular epidemiology of multidrug-resistant tuberculosis, New York City, 1995-1997. Emerg Infect Dis 2002;81230-8.Small 1994
Small PA, Hopewell PC, Singh SP, et al. The epidemiology of tuberculosis in San Francisco, a population-based study using conventional and molecular methods. N Engl J Med 1994;330:1703-9.van Embden 1993
van Embden JDA, Cave MD, Crawford JT, et al. Strain identification of *Mycobacterium tuberculosis* by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol 1993;31:406-9.Vynnycky 2003
Vynnycky E, Borgdorff MW, van Soolingen D, Fine EM. Annual *Mycobacterium tuberculosis* infection risk and interpretation of clustering statistics. Emerg Infect Dis 2003;9:176-83.Yeh 1999
Yeh RW, Hopewell PC, Daley CL. Simultaneous infection with two strains of *Mycobacterium tuberculosis* identified by restriction fragment length polymorphism analysis. Int J Tuberc Lung Dis 1999;3:537-9.
							
					
						Page last reviewed:  September 1, 2012					Content source: 	Division of Tuberculosis Elimination, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention homeGuide to the Application of Genotyping to Tuberculosis Prevention and Control
Acknowledgments
Introduction to Tuberculosis Genotypingplus icon
Introduction to this Guide
Overview of Tuberculosis Genotyping
Overview of the CDC Tuberculosis Genotyping Program
TB Program Eligibility and Application Procedures
Tuberculosis Genotyping Case Studiesplus icon
Investigation of a Genotyping Cluster in a Low-Incidence State
Apparent Genotyping Cluster among Recent Immigrants from the Philippines
False-Positive Culture Investigation
Algorithm to Detect False-Positive Cultures
A Misdiagnosis that was Identified with Genotyping
Genotyping Used to Improve Contact and Cluster Investigations
Identification of Nontraditional Transmission Settings
Investigation of a Multistate Tuberculosis Outbreak
Homeless Shelter Outbreak Investigation
Using Genotyping to Evaluate the Impact of a Screening Program
CDC Tuberculosis Genotyping Laboratory Proceduresplus icon
Science behind Tuberculosis Genotyping
Description of Genotyping Methods
Submission of Isolates
Genotyping Results, Designation of Clusters, and Reporting
Suspected False-Positive Cultures
IS*6110*-based RFLP Analysis
Combining Genotyping and Epidemiologic Data to Improve Our Understanding of TB Transmissionplus icon
Definitions
Reading the Genotyping Laboratory Report
Comparing Genotyping and Epidemiologic Results from Two TB Patients
Comparing Genotyping and Epidemiologic Results from Three or More TB Patients
Clustering as a Surrogate Measure of Recent Transmission
Developing a Tuberculosis Genotyping Programplus icon
Developing a Written Plan
Initial Decisions
Establishing Procedures for:plus icon
Submitting Isolates
Receiving and Acting on Genotyping Results
Requesting RFLP Analysis
Submitting Additional Isolates from the Same Patient
Comparing Genotyping Results between Jurisdictions
False-Positive Cultures
Database Management and Quality Control
Special Issues
Applying Genotyping Results to Tuberculosis Control Practicesplus icon
Evaluating Matching Genotypes
Evaluating Nonmatching Genotypes
Suspected False-Positive Culture Investigations
Expanded Contact Investigations
Outbreak Investigations
Cluster Investigations
Monitoring Trends
Appendicesplus icon
Appendix A: Glossary and Abbreviations
Appendix B: References and Useful Resourcesplus icon
References Cited in the Guide
NTGSN Special Issue References
Information on Packaging and Shipping Infectious Substances
Core Steps of an Outbreak Investigation
Consultants Available to Offer Guidance To receive email updates about this page, enter your email address: Email Address			What's this?				Submit


About CDC
					Contact Us
					800-232-4636
 Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
 CONTACT CDC
				Contact Us
							Call 800-232-4636
							Email Us
			ABOUT CDC
				About CDC
							Jobs
							Funding
			POLICIES
				Accessibility
							External Links
							Privacy
							Policies
							No Fear Act
							FOIA
							OIG
							Nondiscrimination
							Vulnerability Disclosure Policy
			CONNECT WITH US
				Facebook
								Twitter
								Instagram
								LinkedIn
							Youtube
								Pinterest
								Snapchat
								Email
			LANGUAGES
				Español
							繁體中文
							Tiếng Việt
							한국어
							Tagalog
							Русский
							العربية
							Kreyòl Ayisyen
							Français
							Polski
							Português
							Italiano
							Deutsch
							日本語
							فارسی
							English


U.S. Department of Health & Human Services
			Accessibility
			External Links
			Privacy
			Policies
			No Fear Act
			FOIA
			Nondiscrimination
			OIG
			Vulnerability Disclosure Policy
			USA.gov


Exit Notification / Disclaimer Policy Close
 Links with this icon  indicate that you are leaving the CDC website. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
				Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
				You will be subject to the destination website's privacy policy when you follow the link.
				CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Website Disclaimers
 Cancel Continue